Legal considerations in screening pregnant women for human immunodeficiency virus

被引:8
|
作者
Grimes, RM
Richards, EP
Helfgott, AW
Eriksen, NL
机构
[1] Univ Texas, Hlth Sci Ctr, AIDS Educ & Training Ctr Texas & Oklahoma, Sch Publ Hlth, Houston, TX 77225 USA
[2] Univ Texas, Sch Publ Hlth, Dept Management & Policy Sci, Houston, TX 77225 USA
[3] Univ Missouri, Kansas City, MO 64110 USA
[4] Univ Texas, Hlth Sci Ctr, Womens Immunol Ctr, Sch Med, Houston, TX USA
[5] Univ Texas, Hlth Sci Ctr, Div Maternal Fetal Med, Houston, TX USA
关键词
human immunodeficiency virus testing in pregnancy; legal liability; informed consent;
D O I
10.1016/S0002-9378(99)70197-3
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
This article examines the legal implications of studies showing that the probability of maternal-to-infant human immunodeficiency virus transmission can be reduced by physician interventions. These interventions require knowledge of a pregnant woman's human immunodeficiency status. Hence the offering of human immunodeficiency virus testing has become a standard of care in pregnancy. This standard of care is examined with respect to the following: (1) the physician's legal duty to the infant, (2) negligence for failing to test, (3) liability when testing only reduces the probability of transmission, (4) damages, (5) informing women about the results of their testing, (6) protecting against liability, and (7) dealing with human immunodeficiency virus-infected pregnant women. It is concluded that the physicians are likely to have legal difficulties if a human immunodeficiency virus-infected baby is born to a woman who was not offered testing or if testing is done without documenting consent. Suggestions are made for reducing liability when testing is done, when patients refuse testing, and when one is caring for human immunodeficiency virus-infected women.
引用
收藏
页码:259 / 264
页数:6
相关论文
共 50 条
  • [1] MANDATORY SCREENING OF PREGNANT-WOMEN FOR HUMAN-IMMUNODEFICIENCY-VIRUS
    STAHL, AJ
    SMITH, RM
    SCHAENING, O
    LUTWICK, LI
    [J]. CLINICAL INFECTIOUS DISEASES, 1995, 20 (03) : 732 - 732
  • [2] MANDATORY SCREENING OF PREGNANT-WOMEN FOR THE HUMAN-IMMUNODEFICIENCY-VIRUS
    WILFERT, CM
    [J]. CLINICAL INFECTIOUS DISEASES, 1994, 19 (04) : 664 - 666
  • [3] Recommendations for human immunodeficiency virus screening, prophylaxis, and treatment for pregnant women in the United States
    Jamieson, Denise J.
    Clark, Jill
    Kourtis, Athena P.
    Taylor, Allan W.
    Lampe, Margaret A.
    Fowler, Mary Glenn
    Mofenson, Lynne M.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 197 (03) : S26 - S32
  • [4] DRUG PROPHYLAXIS FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTED PREGNANT-WOMEN - ETHICAL CONSIDERATIONS
    MINKOFF, HL
    MORENO, JD
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (04) : 1111 - 1114
  • [5] Human immunodeficiency virus infection in pregnant women and their newborns
    Lindsay, MK
    Nesheim, SR
    [J]. CLINICS IN PERINATOLOGY, 1997, 24 (01) : 161 - +
  • [6] Prevalence of Human Immunodeficiency Virus Among Pregnant Women
    Kurtay, Sabri
    Hussein, Ahmed Issak
    [J]. INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2022, 14 : 1803 - 1806
  • [7] Human immunodeficiency virus infection in pregnant women in Nigeria
    Sagay, AS
    Imade, GE
    Nwokedi, EE
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1999, 66 (02) : 183 - 184
  • [8] Abnormal trisomy 21 serum screening in pregnant women infected with human immunodeficiency virus.
    Laibl, VR
    Sheffield, JS
    McIntire, DD
    Wendel, GD
    Dashe, JS
    [J]. JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2005, 12 (02) : 313A - 314A
  • [9] Pharmaceutical care to pregnant women carrying human immunodeficiency virus
    Romeu, Geysa Aguiar
    de Paiva, Larissa Varela
    Moura Fe, Mariana Mota
    [J]. BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 45 (03) : 593 - 602
  • [10] Prevalence of Human Immunodeficiency Virus among pregnant women in Nigeria
    Ozim, C.
    Mahendran, R.
    Amalan, M.
    Puthussery, S.
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2020, 30 : V892 - V892